Loading…
Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs
The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR)...
Saved in:
Published in: | Japanese Journal of Pharmacology 1995, Vol.68(3), pp.245-253 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23 |
---|---|
cites | cdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23 |
container_end_page | 253 |
container_issue | 3 |
container_start_page | 245 |
container_title | Japanese Journal of Pharmacology |
container_volume | 68 |
creator | Iida, Masashi Fujita, Naomi Hosono, Makoto Sukenaga, Yoshikazu |
description | The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator. |
doi_str_mv | 10.1254/jjp.68.245 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77525960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021519819354885</els_id><sourcerecordid>77525960</sourcerecordid><originalsourceid>FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</originalsourceid><addsrcrecordid>eNptkU1v1DAQhiMEKkvhwh3JB8QBNYu_kxzLttsiqoIEiKPldSZdBzde7GQl_j2zyrInDvbImlePR88UxWtGl4wr-aHvd0tdL7lUT4oFE7IqhaL6abGglLNSsaZ-XrzIucdnTZk8K84qWUklq0URP6Y4uG1sfbBjTMQOLVnZ1Pq4t9lNwSZy3XXgxkxiR-4_38qquiCW3Mc9BPLTjpDKbzFMmwBkHVP-FYMfyBUkv7ej38MFwefN5Aew5Kt_yC-LZ50NGV4d63nxY339fXVb3n25-bS6vCudrsVYagfcar6pWAsN01IKPEpbwetOOmW5E61uXSPahlFn61aCqhvXUSlqV224OC_ezdxdir8nyKN59NlBCHaAOGVTVYqrRlMMvp-DLsWcE3Rml_yjTX8Mo-Zg16Bdo2uDdjH85kidNo_QnqJHndh_e-yjPBu6ZAfn8ykmNOWKS4yt5xgyPObigNLA9HFKA0oxrtN9H3fBsKZRhlJdU4GFG4pD4KVEQxvNDqCrGdTn0T7A6SObRu8CEnfbzBrFDvOL-ToQ_rXd1iYDA2LkjAHcyN5DMtl5GBxOl3D1po3-fzb-AqrIwc4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77525960</pqid></control><display><type>article</type><title>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</title><source>ScienceDirect</source><creator>Iida, Masashi ; Fujita, Naomi ; Hosono, Makoto ; Sukenaga, Yoshikazu</creator><creatorcontrib>Iida, Masashi ; Fujita, Naomi ; Hosono, Makoto ; Sukenaga, Yoshikazu ; Nippon Kayaku Co ; Research and Development Division ; Ltd ; Pharmaceuticals Group</creatorcontrib><description>The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.</description><identifier>ISSN: 0021-5198</identifier><identifier>EISSN: 1347-3506</identifier><identifier>DOI: 10.1254/jjp.68.245</identifier><identifier>PMID: 7474547</identifier><identifier>CODEN: JJPAAZ</identifier><language>eng</language><publisher>Kyoto: The Japanese Pharmacological Society</publisher><subject>Animals ; Biological and medical sciences ; Blood pressure ; Blood Pressure - drug effects ; Bronchodilator ; Bronchodilator Agents - pharmacology ; Colforsin - analogs & derivatives ; Colforsin - pharmacology ; Dose-Response Relationship, Drug ; Guinea Pigs ; Heart rate ; Heart Rate - drug effects ; Injections, Intravenous ; Male ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; NKH477 ; Pharmacology. Drug treatments ; Respiratory system ; Time Factors ; Vasodilator Agents - pharmacology</subject><ispartof>The Japanese Journal of Pharmacology, 1995, Vol.68(3), pp.245-253</ispartof><rights>1995 Elsevier B.V.</rights><rights>The Japanese PharmacologicalSociety</rights><rights>1995 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</citedby><cites>FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021519819354885$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3602524$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7474547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iida, Masashi</creatorcontrib><creatorcontrib>Fujita, Naomi</creatorcontrib><creatorcontrib>Hosono, Makoto</creatorcontrib><creatorcontrib>Sukenaga, Yoshikazu</creatorcontrib><creatorcontrib>Nippon Kayaku Co</creatorcontrib><creatorcontrib>Research and Development Division</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>Pharmaceuticals Group</creatorcontrib><title>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</title><title>Japanese Journal of Pharmacology</title><addtitle>Jpn.J.Pharmacol.</addtitle><description>The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Bronchodilator</subject><subject>Bronchodilator Agents - pharmacology</subject><subject>Colforsin - analogs & derivatives</subject><subject>Colforsin - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Guinea Pigs</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>NKH477</subject><subject>Pharmacology. Drug treatments</subject><subject>Respiratory system</subject><subject>Time Factors</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0021-5198</issn><issn>1347-3506</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNptkU1v1DAQhiMEKkvhwh3JB8QBNYu_kxzLttsiqoIEiKPldSZdBzde7GQl_j2zyrInDvbImlePR88UxWtGl4wr-aHvd0tdL7lUT4oFE7IqhaL6abGglLNSsaZ-XrzIucdnTZk8K84qWUklq0URP6Y4uG1sfbBjTMQOLVnZ1Pq4t9lNwSZy3XXgxkxiR-4_38qquiCW3Mc9BPLTjpDKbzFMmwBkHVP-FYMfyBUkv7ej38MFwefN5Aew5Kt_yC-LZ50NGV4d63nxY339fXVb3n25-bS6vCudrsVYagfcar6pWAsN01IKPEpbwetOOmW5E61uXSPahlFn61aCqhvXUSlqV224OC_ezdxdir8nyKN59NlBCHaAOGVTVYqrRlMMvp-DLsWcE3Rml_yjTX8Mo-Zg16Bdo2uDdjH85kidNo_QnqJHndh_e-yjPBu6ZAfn8ykmNOWKS4yt5xgyPObigNLA9HFKA0oxrtN9H3fBsKZRhlJdU4GFG4pD4KVEQxvNDqCrGdTn0T7A6SObRu8CEnfbzBrFDvOL-ToQ_rXd1iYDA2LkjAHcyN5DMtl5GBxOl3D1po3-fzb-AqrIwc4</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Iida, Masashi</creator><creator>Fujita, Naomi</creator><creator>Hosono, Makoto</creator><creator>Sukenaga, Yoshikazu</creator><general>The Japanese Pharmacological Society</general><general>Japanese Pharmacological Society</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</title><author>Iida, Masashi ; Fujita, Naomi ; Hosono, Makoto ; Sukenaga, Yoshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Bronchodilator</topic><topic>Bronchodilator Agents - pharmacology</topic><topic>Colforsin - analogs & derivatives</topic><topic>Colforsin - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Guinea Pigs</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>NKH477</topic><topic>Pharmacology. Drug treatments</topic><topic>Respiratory system</topic><topic>Time Factors</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Iida, Masashi</creatorcontrib><creatorcontrib>Fujita, Naomi</creatorcontrib><creatorcontrib>Hosono, Makoto</creatorcontrib><creatorcontrib>Sukenaga, Yoshikazu</creatorcontrib><creatorcontrib>Nippon Kayaku Co</creatorcontrib><creatorcontrib>Research and Development Division</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>Pharmaceuticals Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese Journal of Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iida, Masashi</au><au>Fujita, Naomi</au><au>Hosono, Makoto</au><au>Sukenaga, Yoshikazu</au><aucorp>Nippon Kayaku Co</aucorp><aucorp>Research and Development Division</aucorp><aucorp>Ltd</aucorp><aucorp>Pharmaceuticals Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</atitle><jtitle>Japanese Journal of Pharmacology</jtitle><addtitle>Jpn.J.Pharmacol.</addtitle><date>1995</date><risdate>1995</risdate><volume>68</volume><issue>3</issue><spage>245</spage><epage>253</epage><pages>245-253</pages><issn>0021-5198</issn><eissn>1347-3506</eissn><coden>JJPAAZ</coden><abstract>The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.</abstract><cop>Kyoto</cop><pub>The Japanese Pharmacological Society</pub><pmid>7474547</pmid><doi>10.1254/jjp.68.245</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-5198 |
ispartof | The Japanese Journal of Pharmacology, 1995, Vol.68(3), pp.245-253 |
issn | 0021-5198 1347-3506 |
language | eng |
recordid | cdi_proquest_miscellaneous_77525960 |
source | ScienceDirect |
subjects | Animals Biological and medical sciences Blood pressure Blood Pressure - drug effects Bronchodilator Bronchodilator Agents - pharmacology Colforsin - analogs & derivatives Colforsin - pharmacology Dose-Response Relationship, Drug Guinea Pigs Heart rate Heart Rate - drug effects Injections, Intravenous Male Medical sciences Muscle, Smooth, Vascular - drug effects NKH477 Pharmacology. Drug treatments Respiratory system Time Factors Vasodilator Agents - pharmacology |
title | Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A26%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchodilator%20and%20Cardiovascular%20Effects%20of%20NKH477,%20a%20Novel%20Water-Soluble%20Forskolin%20Derivative,%20in%20Guinea%20Pigs&rft.jtitle=Japanese%20Journal%20of%20Pharmacology&rft.au=Iida,%20Masashi&rft.aucorp=Nippon%20Kayaku%20Co&rft.date=1995&rft.volume=68&rft.issue=3&rft.spage=245&rft.epage=253&rft.pages=245-253&rft.issn=0021-5198&rft.eissn=1347-3506&rft.coden=JJPAAZ&rft_id=info:doi/10.1254/jjp.68.245&rft_dat=%3Cproquest_cross%3E77525960%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77525960&rft_id=info:pmid/7474547&rfr_iscdi=true |